JALEX Medical serves clients across the globe. Schedule Your Consultation today.
End-to-end device engineering, quality systems, and regulatory expertise, delivered with speed, rigor, and accountability to accelerate your device to market.
500+
Projects Delivered
20+
Medical Specialties Supported
60 +
510K and De Novo Clearances
From startups to global Fortune 500 medical manufacturers, companies trust JALEX Medical to execute critical device development with speed and rigor for more than 13+ years
End-to-end engineering, quality, and regulatory execution across the full development cycle, reducing risk, eliminating unnecessary time and cost, and delivering commercial ready results.

Help medical device companies understand, implement and comply with ISO 14971 risk management standards. This includes identifying hazards, analyzing risks, and implementing effective mitigation strategies.

Help medical device companies understand, implement and comply with ISO 14971 risk management standards. This includes identifying hazards, analyzing risks, and implementing effective mitigation strategies.
Give us your project details and challenges, and receive a free consultation on how Jalex Medical can help you.
Follow us on LinkedIn to see the upcoming events that our team will be attending.
JALEX Medical supports Class I and Class II devices across 20+ medical specialties, partnering with innovators in orthopedics, spine, neurology, sports medicine, extremities, gynecology, urology, trauma, capital equipment, and software-enabled computer assisted navigation technologies.
Our team delivers end-to-end engineering, quality, and regulatory execution, guiding devices and their leadership teams through 510(k), De Novo, and global pathways.
The timeline varies depending on device complexity, classification, regulatory pathway, testing requirements, and manufacturing readiness. For most Class I and Class II devices, development and regulatory clearance can range from several months to multiple years.
JALEX helps accelerate that timeline by integrating engineering, quality, and regulatory strategy from day one. Because our team consists of in-house experts working collaboratively across all active projects daily, we maintain full visibility across development, documentation, testing, and submission requirements, ensuring efficient execution, reduced rework, and steady progress toward market clearance.
Yes. JALEX provides comprehensive support for U.S. and international regulatory submissions, including FDA and global market pathways. Whether leading full submission execution or strengthening existing documentation, we integrate engineering, quality, and regulatory expertise to deliver clear and globally aligned submissions that support efficient market entry.
Beyond execution, we advise on effective regulatory strategies that align with sound business planning, helping you evaluate pathways, sequencing, global expansion considerations, and long-term commercialization goals to ensure regulatory decisions support overall growth strategy.
JALEX begins every project with the end user in mind, developing a clear understanding of the intended clinical use by aligning with your design team and, when appropriate, engaging directly in the real-world use environment to ground development decisions in clinical reality.
With that foundation, we define the regulatory strategy and pathway early, aligning timelines, milestones, testing requirements, and submission objectives to ensure clarity and achievable execution.
We then apply a structured, milestone-driven framework integrating engineering, quality, and regulatory expertise under one accountable team. Our organizational model allows us to assume full project ownership when desired or integrate seamlessly as an extension of your internal team.
Because our experts collaborate cross-functionally in-house across active projects daily, we maintain real-time visibility into project scope, timeline and budget progress.
Yes. Medical device projects often stall due to fragmented execution between engineering and regulatory teams, unclear regulatory strategy, incomplete design controls, documentation gaps, or shifting scope without aligned timelines.
JALEX specializes in stabilizing and realigning delayed programs. We conduct a targeted assessment to identify gaps in design controls, testing, quality documentation, and regulatory strategy, then implement a disciplined recovery plan to restore momentum and drive the project toward commercialization.
As outsourcing services continues to expand in the medical device market, driven by cost control and the need for speed, JALEX delivers fully integrated engineering, quality, and regulatory execution across the entire development lifecycle.
Our in-house experts operate as one aligned team, eliminating silos, reducing rework, and accelerating progress from concept through commercialization. We act as an extension of your organization, providing strategic guidance, regulatory insight, and hands-on execution so your team stays aligned and informed at every stage.
Supported by our network of leading partners in medical manufacturing, sterilization, validation testing, and packaging, we bring a comprehensive, coordinated solution to your program.
The result: faster, more predictable market entry, while you stay focused on broader business strategy and portfolio growth.